Safety and Tolerability of GalNAc3-Conjugated Antisense Drugs Compared to the Same-Sequence 2′-O-Methoxyethyl-Modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial Data
Baker B.F., Xia, S., Partridge, W., Engelhardt, J.A., Tsimikas, S., Crooke, S.T., Bhanot, S., Geary, R.S. Download PDF